Loratadine and Enterovesical fistula - a phase IV clinical study of FDA data

Summary:

We study 50,414 people who have side effects when taking Loratadine. Enterovesical fistula is found, especially among people who are female, 60+ old, also take Percocet and have Multiple myeloma.

The phase IV clinical study analyzes which people take Loratadine and have Enterovesical fistula. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

On Sep, 25, 2023

50,414 people reported to have side effects when taking Loratadine.
Among them, 13 people (0.03%) have Enterovesical fistula.

What is Loratadine?

Loratadine has active ingredients of loratadine. It is used in allergies. Currently, eHealthMe is studying from 52,686 Loratadine users.

What is Enterovesical fistula?

Enterovesical fistula is found to be associated with 477 drugs and 241 conditions by eHealthMe. Currently, we are studying 928 people who have Enterovesical fistula.

Number of Loratadine and Enterovesical fistula reports submitted per year:

Could Loratadine cause Enterovesical fistula?

Gender of people who have Enterovesical fistula when taking Loratadine *:

female: 92.31 %
male: 7.69 %

Age of people who have Enterovesical fistula when taking Loratadine *:

Common drugs people take besides Loratadine *:

Common side effects people have besides Enterovesical fistula *:

Weight Loss: 12 people, 92.31%
Intervertebral Disc Degeneration (spinal disc degeneration): 12 people, 92.31%
Osteopenia (a condition where bone mineral density is lower than normal): 12 people, 92.31%
Fever: 12 people, 92.31%
Orthopnea (shortness of breath (dyspnea) when lying down): 12 people, 92.31%
Oropharyngeal Pain: 12 people, 92.31%
Oedema Peripheral (superficial swelling): 12 people, 92.31%
Breathing Difficulty: 12 people, 92.31%
Multiple Myeloma (cancer of the plasma cells): 12 people, 92.31%
Mouth Ulcers: 12 people, 92.31%

Common conditions people have *:

Multiple Myeloma (cancer of the plasma cells): 12 people, 92.31%
Restless Leg Syndrome (a powerful urge to move your legs): 1 person, 7.69%
Prostatomegaly (enlargement of the prostate): 1 person, 7.69%
Neuropathy Peripheral (surface nerve damage): 1 person, 7.69%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 7.69%
High Blood Pressure: 1 person, 7.69%
High Blood Cholesterol: 1 person, 7.69%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 7.69%
Enlarged Prostate: 1 person, 7.69%
Diabetes: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Loratadine and have Enterovesical fistula?

Check whether Enterovesical fistula is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Enterovesical fistula and when was it recovered:

Enterovesical fistula in Loratadine

Expand to all the drugs that have ingredients of loratadine:

Enterovesical fistula and drugs with ingredients of loratadine

Alternative drugs to, pros and cons of Loratadine:

Loratadine (52,686 reports)

Browse all side effects of Loratadine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Enterovesical fistula treatments and more:

Enterovesical fistula (928 reports)

Common drugs associated with Enterovesical fistula:

Humira: 178 reports

How the study uses the data?

The study uses data from the FDA. It is based on loratadine (the active ingredients of Loratadine) and Loratadine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.